Wellgistics Health, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a WGRX research report →
Companywww.wellgisticshealth.com
Wellgistics Health, Inc. operates as a wholesaler and distributor of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company distributes generic and branded pharmaceuticals, as well as over-the-counter healthcare and consumer products.
- CEO
- Prashant Patel
- IPO
- 2025
- Employees
- 31
- HQ
- Tampa, FL, US
Price Chart
Valuation
- Market Cap
- $9.15M
- P/E
- -0.18
- P/S
- 0.65
- P/B
- -0.90
- EV/EBITDA
- -0.71
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -72.40%
- Op Margin
- -398.05%
- Net Margin
- -545.72%
- ROE
- 1545.09%
- ROIC
- -408.69%
Growth & Income
- Revenue
- $23.34M · 28.73%
- Net Income
- $-101,274,530 · -1377.12%
- EPS
- $-1.43 · -1000.00%
- Op Income
- $-81,194,831
- FCF YoY
- -577.47%
Performance & Tape
- 52W High
- $2.66
- 52W Low
- $0.07
- 50D MA
- $0.12
- 200D MA
- $0.52
- Beta
- -1.16
- Avg Volume
- 27.72M
Get TickerSpark's AI analysis on WGRX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 31, 26 | Patel Prashant | other | 5,000,000 |
| Mar 31, 26 | Patel Prashant | other | 5,000,000 |
| Mar 31, 26 | AJJARAPU SURENDRA K | other | 5,000,000 |
| Mar 31, 26 | AJJARAPU SURENDRA K | other | 5,000,000 |
| Feb 4, 26 | Herman Gary L | other | 0 |
| Oct 7, 25 | Sherb Eric Michael | other | 0 |
| Mar 19, 26 | Velez Marlene | other | 0 |
| Oct 2, 25 | Doss Howard A. | other | 0 |
| Oct 2, 25 | Fell Donald G. | other | 0 |
| Oct 2, 25 | Lee Steven Dale | other | 0 |
Our WGRX Coverage
We haven't published any research on WGRX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate WGRX Report →